HIV-1 inhibiting peptides

HIV-1 inhibiting peptides are small protein fragments designed to block the virus from infecting human cells. They work by targeting specific stages of the HIV-1 life cycle, such as preventing the virus from attaching to or entering cells, or stopping it from assembling and replicating inside them. These peptides are engineered to be highly specific, reducing potential side effects, and are studied as potential therapies to help control or prevent HIV infection. Their development is part of ongoing research to find more effective treatments with fewer limitations compared to traditional antiretroviral drugs.